Arthrex
Device Arthroplasty - Implants - Revers Total Shoulder - Modular Glenoid System
PDI 00888867296411
General payments
$2,433,378
Research payments
$296,240
Through program year 2024, $2,433,378 in general payments and $296,240 in research payments were reported against Arthrex (Revers Total Shoulder - Modular Glenoid System).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $1,992 | 32 |
| 2024 | Research | $37,096 | 3 |
| 2023 | Research | $259,144 | 3 |
| 2022 | General | $969,435 | 4 |
| 2021 | General | $1,461,950 | 8 |
Breakdown
The top 5 of 27 recipients; each share is of general payments naming this product in 2024.
The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 15 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
44 general · 6 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.